Synthetic Typhoid Fever Vaccine, Safer And More Economical Approach Against A Major Infectious Disease
DelSite Inc., (OTCBB: DSII) today announced Dr. Yawei Ni, chief scientific officer, of its wholly-owned subsidiary, DelSite Biotechnologies, Inc., presented its innovative GelVac(TM) nasal powder platform for vaccine delivery and the synthetic typhoid vaccine at the 2nd Vaccines Asia Conference held November 10-13, 2008, in Beijing, China. Dr.
More: continued here
Filed under: Immune System / Vaccines on November 21st, 2008